Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]
Click Therapeutics has secured a $50M Series D investment from [...]
Researchers have identified a molecular target that could extend the [...]
BullFrog AI Holdings has entered a commercial agreement with a [...]
Young adults in wealthy countries are four times more likely [...]
Compass Pathways reports positive second Phase 3 trial for COMP360 in treatment-resistant depression
Compass Pathways has reported that its second pivotal Phase 3 [...]
FundaMental Pharma GmbH will present new preclinical data on its [...]
Newron Pharmaceuticals has published peer-reviewed clinical data demonstrating that evenamide, [...]
Wellcome has awarded £5.3m in funding to digital mental health [...]
Mental health systems in the US and UK have entered [...]